RECURRENCE
Chromosome inversion recurrence summary:
  High-quality inversions with consensus labels: 93 (single-event = 61, recurrent = 32).
  Fraction recurrent = 34.41%.

SAMPLE SIZES
Sample sizes for diversity analyses:
  Inversion callset columns indicate 44 phased individuals (sample columns).
  Reporting haplotypes as twice the sample count yields 88 potential phased haplotypes.
  Loci with ≥2 haplotypes per orientation for π: 60 (from output.csv).

DIVERSITY
Nucleotide diversity (π) by orientation and recurrence:
  Total loci with finite π estimates: 67.
  Across all loci: mean π(inverted) = 0.000273, mean π(direct) = 0.000387.
    Two-sided paired t-test comparing orientations: t = -2.870, p = 5.505e-03.
  Single-event inversions: median π(inverted) = 6.000000e-06, median π(direct) = 0.000233.
  Recurrent inversions: median π(inverted) = 0.000359, median π(direct) = 0.000442.
  Within inverted haplotypes: recurrent median π = 0.000359; single-event median π = 6.000000e-06.

LINEAR MODEL
Orientation × recurrence linear model on log π ratios (Model A):
  Detection floor applied before logs: ε = 6.325000e-06.
  Single-event: Inverted vs Direct: fold-change = 0.279 (95% CI 0.151–0.515), p = 4.427e-05.
  Recurrent: Inverted vs Direct: fold-change = 1.099 (95% CI 0.905–1.336), p = 0.341.
  Interaction (difference between those two): fold-change = 3.941 (95% CI 2.072–7.497), p = 2.910e-05.
  Overall inversion effect (pooled Δ-logπ): fold-change = 0.537 (95% CI 0.372–0.776), p = 9.424e-04.

DIFFERENTIATION
Differentiation between orientations (Hudson's FST):
  Single-event: median FST = 0.325 (n = 28).
  Recurrent: median FST = 0.070 (n = 32).
  Mann–Whitney U test (single-event vs recurrent): U = 628.000, p = 7.680e-03.
  Highly differentiated loci: 26 with FST > 0.2 and 10 with FST > 0.5.

BREAKPOINT FRF
Breakpoint enrichment (flat–ramp–flat model deltas):
  Single-event: mean(FST_flank - FST_middle) = 0.043 (n = 14).
  Recurrent: mean(FST_flank - FST_middle) = -0.079 (n = 17).
  Difference-of-differences (single-event minus recurrent): 0.122.

IMPUTATION
Imputation performance summary:
  Models evaluated: 158; models with r² > 0.3 and BH p < 0.05: 30.
  Models flagged for downstream PheWAS (Use == True): 30.

PHEWAS SCALE
PheWAS scale summary:
  Unique phenotypes tested: 1089.
  Case counts span 1002 to 137692; controls span 182133–368254.
  Phenotype coverage per inversion (top 5): chr10-79542902-INV-674513: 1089, chr12-46897663-INV-16289: 1089, chr17-45585160-INV-706887: 1089, chr4-33098029-INV-7075: 1089, chr6-141867315-INV-29159: 1089; ...
  Inversions with ≥1 BH-significant phenotype: 4 of 6.

KEY ASSOCIATIONS
Selected inversion–phenotype associations (logistic regression with LRT p-values):
  Source tables: phewas_results.tsv, all_pop_phewas_tag.tsv.
  chr10-79542902-INV-674513 vs Positive DNA test for high-risk HPV types: OR = 1.241 (95% CI 1.114–1.382), BH-adjusted p ≈ 0.032 (raw p = 1.144e-04).
  chr6-141867315-INV-29159 vs Laryngitis and tracheitis: OR = 0.572 (95% CI 0.491–0.751), BH-adjusted p ≈ 0.041 (raw p = 2.193e-04).
  chr12-46897663-INV-16289 vs Conjunctivitis: OR = 1.147 (95% CI 1.091–1.205), BH-adjusted p ≈ 1.970e-04 (raw p = 9.630e-08).
  chr12-46897663-INV-16289 vs Migraine: OR = 1.086 (95% CI 1.044–1.103), BH-adjusted p ≈ 0.040 (raw p = 1.717e-04).
  chr17-45974480-INV-29218 vs Morbid obesity: OR = 1.054 (95% CI 1.031–1.078), BH-adjusted p ≈ 8.151e-04 (raw p = 3.650e-06).
  chr17-45974480-INV-29218 vs Breast lump or abnormal exam: OR = 0.956 (95% CI 0.936–0.977), BH-adjusted p ≈ 6.375e-03 (raw p = 4.280e-05).
  chr17-45974480-INV-29218 vs Abnormal mammogram: OR = 0.939 (95% CI 0.910–0.969), BH-adjusted p ≈ 7.326e-03 (raw p = 6.870e-05).

CATEGORY TESTS
Phecode category omnibus and directional tests:
  chr12-46897663-INV-16289: Gastrointestinal: GBJ p = 2.000e-05, GLS p = 9.320e-05; Genitourinary: GBJ p = 2.000e-05, GLS p = 1.817e-04; Neoplasms: GBJ p = 2.000e-05, GLS p = 1.500e-04; Dermatological: GBJ p = 2.000e-05, GLS p = 2.410e-06; Symptoms: GBJ p = 8.570e-05, GLS p = 1.390e-04; Sense organs: GBJ p = 1.143e-04, GLS p = 9.060e-03; Muscloskeletal: GBJ p = 2.000e-04, GLS p = 0.057; Endocrine/Metab: GBJ p = 1.600e-03, GLS p = 1.688e-03; Respiratory: GBJ p = 1.600e-03, GLS p = 9.401e-03; Neurological: GBJ p = 0.012, GLS p = 0.308; Cardiovascular: GBJ p = 0.132, GLS p = 0.030; Mental: GBJ p = 0.386, GLS p = 0.036
  chr17-45585160-INV-706887: Symptoms: GBJ p = 2.000e-05, GLS p = 2.239e-04; Neoplasms: GBJ p = 2.000e-05, GLS p = 5.800e-05; Dermatological: GBJ p = 2.000e-05, GLS p = 1.380e-03; Gastrointestinal: GBJ p = 3.999e-04, GLS p = 9.044e-03; Neurological: GBJ p = 3.999e-04, GLS p = 0.068; Endocrine/Metab: GBJ p = 5.999e-04, GLS p = 0.107; Respiratory: GBJ p = 7.998e-04, GLS p = 0.044; Sense organs: GBJ p = 2.999e-03, GLS p = 0.171; Muscloskeletal: GBJ p = 4.599e-03, GLS p = 0.033; Cardiovascular: GBJ p = 0.013, GLS p = 0.615; Blood/Immune: GBJ p = 0.170, GLS p = 0.010
  chr4-33098029-INV-7075: Blood/Immune: GBJ p = 0.112, GLS p = 0.038; Respiratory: GBJ p = 0.199, GLS p = 0.029
  chr6-141867315-INV-29159: Blood/Immune: GBJ p = 0.025, GLS p = 0.712; Respiratory: GBJ p = 0.044, GLS p = 0.625
  chr6-167181003-INV-209976: Infections: GBJ p = 0.369, GLS p = 7.906e-03

PGS CONTROLS
Sensitivity of PheWAS associations to regional PGS covariates:
  Source table: PGS_controls.tsv.
  Largest p-value inflation: inversion chr17-45585160-INV-706887 × Morbid_obesity (p_nominal = 7.940e-09, p_with_pgs = 8.476e-03, fold-change = 1.068e+06).

SELECTION
Ancient DNA-based selection inferences (AGES trajectory 12_47296118_A_G):
  Windows analyzed: 101 spanning 0–1e+04 years before present.
  Model frequency pₜ ranges 0.025–0.084; net change from 1e+04 to 0 years BP is 0.059.
  Median haploid sample size per window ≈ 1e+03 alleles.
  Largest ~1,000-year change: Δpₜ ≈ 6.710e-03 between 0 and 1e+03 years BP.
